KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Accounts Payables (2016 - 2025)

LifeMD (LFMD) has disclosed Accounts Payables for 14 consecutive years, with $14.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables rose 29.75% year-over-year to $14.1 million, compared with a TTM value of $14.1 million through Dec 2025, up 29.75%, and an annual FY2025 reading of $14.1 million, up 29.75% over the prior year.
  • Accounts Payables was $14.1 million for Q4 2025 at LifeMD, down from $19.6 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $24.3 million in Q2 2025 and bottomed at $6.9 million in Q1 2023.
  • Average Accounts Payables over 5 years is $12.7 million, with a median of $11.7 million recorded in 2021.
  • The sharpest move saw Accounts Payables soared 101.48% in 2021, then tumbled 40.88% in 2023.
  • Year by year, Accounts Payables stood at $9.1 million in 2021, then grew by 11.56% to $10.1 million in 2022, then rose by 9.68% to $11.1 million in 2023, then decreased by 1.63% to $10.9 million in 2024, then rose by 29.75% to $14.1 million in 2025.
  • Business Quant data shows Accounts Payables for LFMD at $14.1 million in Q4 2025, $19.6 million in Q3 2025, and $24.3 million in Q2 2025.